Company – Scrape Financial
Risk Factors Summary

Risk Factors Update Summary

  • Expanded TAG program aims to generate $300 million annualized operating income benefits, targeting at least $100 million by 2025.
  • Implemented "Transform and Grow" restructuring plan expected to generate $300 million annualized operating income benefits by 2025.
  • Sales of watches accounted for approximately 77.6% in 2023, 77.9% in 2022, and 80.9% in 2021.
  • Closed 55 stores in fiscal year 2024, aiming to close approximately 60 stores globally.
  • Increased digital sales comprised 37% of consolidated net sales in 2023, focusing on improving end-to-end consumer experience.
  • Net sales from licensed products decreased from 46% to 44% of consolidated net sales.
  • Actions requiring shareholder vote added, impacting corporate decisions and potentially causing disagreements.
  • Transitioned to a more unified operational structure, enhancing efficiency and increasing digital investments.
  • Mention of inflation, rising interest rates, and their impact on capital markets included.
  • Enhanced DE&I strategy includes goals to increase BIPOC representation, with nearly 50% of external hires being BIPOC.
  • Reference to economic growth and high unemployment retained in risk factors.
  • Launched the "WINGEd" program for female managers, focusing on skills development and self-awareness.
  • Established a Special Committee of the Board in 2023 to oversee strategic transformation initiatives, including organizational restructuring.

Full Text Changes in Most Recent 10-K

Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.

To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=883569&owner=exclude

Click here to download the PDF

This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.